+1 (704) 266-3234

Global And China Non-opioid Pain Patches Market Insights, Forecast To 2027

Published on: Oct 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 142

Non-opioid Pain Patches market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Non-opioid Pain Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Non-opioid Pain Patches market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others

Segment by Application
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International

1 Study Coverage
1.1 Non-opioid Pain Patches Product Introduction
1.2 Market by Type
1.2.1 Global Non-opioid Pain Patches Market Size Growth Rate by Type
1.2.2 Lidocaine Patch
1.2.3 Diclofenac Patch
1.2.4 Methyl Salicylate Patch
1.2.5 Capsaicin Patch
1.2.6 Ketoprofen Patch
1.2.7 Others
1.3 Market by Application
1.3.1 Global Non-opioid Pain Patches Market Size Growth Rate by Application
1.3.2 Hospital Pharmacies
1.3.3 Independent Pharmacies & Drug Stores
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Non-opioid Pain Patches Market Size, Estimates and Forecasts
2.1.1 Global Non-opioid Pain Patches Revenue 2016-2027
2.1.2 Global Non-opioid Pain Patches Sales 2016-2027
2.2 Global Non-opioid Pain Patches, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Non-opioid Pain Patches Historical Market Size by Region (2016-2021)
2.3.1 Global Non-opioid Pain Patches Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Non-opioid Pain Patches Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Non-opioid Pain Patches Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Non-opioid Pain Patches Sales Forecast by Region (2022-2027)
2.4.2 Global Non-opioid Pain Patches Revenue Forecast by Region (2022-2027)

3 Global Non-opioid Pain Patches Competitor Landscape by Players
3.1 Global Top Non-opioid Pain Patches Manufacturers by Sales
3.1.1 Global Non-opioid Pain Patches Sales by Manufacturer (2016-2021)
3.1.2 Global Non-opioid Pain Patches Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Non-opioid Pain Patches Manufacturers by Revenue
3.2.1 Key Non-opioid Pain Patches Manufacturers Covered: Ranking by Revenue
3.2.2 Global Non-opioid Pain Patches Revenue by Manufacturers (2016-2021)
3.2.3 Global Non-opioid Pain Patches Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Non-opioid Pain Patches Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Non-opioid Pain Patches Revenue in 2020
3.2.6 Global Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Non-opioid Pain Patches Price by Manufacturers
3.4 Global Non-opioid Pain Patches Manufacturing Base Distribution, Product Types
3.4.1 Non-opioid Pain Patches Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Non-opioid Pain Patches Product Type
3.4.3 Date of International Manufacturers Enter into Non-opioid Pain Patches Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Non-opioid Pain Patches Market Size by Type (2016-2021)
4.1.1 Global Non-opioid Pain Patches Sales by Type (2016-2021)
4.1.2 Global Non-opioid Pain Patches Revenue by Type (2016-2021)
4.1.3 Non-opioid Pain Patches Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Non-opioid Pain Patches Market Size Forecast by Type (2022-2027)
4.2.1 Global Non-opioid Pain Patches Sales Forecast by Type (2022-2027)
4.2.2 Global Non-opioid Pain Patches Revenue Forecast by Type (2022-2027)
4.2.3 Non-opioid Pain Patches Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Non-opioid Pain Patches Market Size by Application (2016-2021)
5.1.1 Global Non-opioid Pain Patches Sales by Application (2016-2021)
5.1.2 Global Non-opioid Pain Patches Revenue by Application (2016-2021)
5.1.3 Non-opioid Pain Patches Price by Application (2016-2021)
5.2 Non-opioid Pain Patches Market Size Forecast by Application (2022-2027)
5.2.1 Global Non-opioid Pain Patches Sales Forecast by Application (2022-2027)
5.2.2 Global Non-opioid Pain Patches Revenue Forecast by Application (2022-2027)
5.2.3 Global Non-opioid Pain Patches Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Non-opioid Pain Patches Market Size YoY Growth 2016-2027
6.1.1 China Non-opioid Pain Patches Sales YoY Growth 2016-2027
6.1.2 China Non-opioid Pain Patches Revenue YoY Growth 2016-2027
6.1.3 China Non-opioid Pain Patches Market Share in Global Market 2016-2027
6.2 China Non-opioid Pain Patches Market Size by Players (International and Local Players)
6.2.1 China Top Non-opioid Pain Patches Players by Sales (2016-2021)
6.2.2 China Top Non-opioid Pain Patches Players by Revenue (2016-2021)
6.3 China Non-opioid Pain Patches Historic Market Review by Type (2016-2021)
6.3.1 China Non-opioid Pain Patches Sales Market Share by Type (2016-2021)
6.3.2 China Non-opioid Pain Patches Revenue Market Share by Type (2016-2021)
6.3.3 China Non-opioid Pain Patches Price by Type (2016-2021)
6.4 China Non-opioid Pain Patches Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Non-opioid Pain Patches Sales Forecast by Type (2022-2027)
6.4.2 China Non-opioid Pain Patches Revenue Forecast by Type (2022-2027)
6.4.3 China Non-opioid Pain Patches Price Forecast by Type (2022-2027)
6.5 China Non-opioid Pain Patches Historic Market Review by Application (2016-2021)
6.5.1 China Non-opioid Pain Patches Sales Market Share by Application (2016-2021)
6.5.2 China Non-opioid Pain Patches Revenue Market Share by Application (2016-2021)
6.5.3 China Non-opioid Pain Patches Price by Application (2016-2021)
6.6 China Non-opioid Pain Patches Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Non-opioid Pain Patches Sales Forecast by Application (2022-2027)
6.6.2 China Non-opioid Pain Patches Revenue Forecast by Application (2022-2027)
6.6.3 China Non-opioid Pain Patches Price Forecast by Application (2022-2027)

7 North America
7.1 North America Non-opioid Pain Patches Market Size YoY Growth 2016-2027
7.2 North America Non-opioid Pain Patches Market Facts & Figures by Country
7.2.1 North America Non-opioid Pain Patches Sales by Country (2016-2021)
7.2.2 North America Non-opioid Pain Patches Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Non-opioid Pain Patches Market Size YoY Growth 2016-2027
8.2 Asia Pacific Non-opioid Pain Patches Market Facts & Figures by Region
8.2.1 Asia Pacific Non-opioid Pain Patches Sales by Region (2016-2021)
8.2.2 Asia Pacific Non-opioid Pain Patches Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Non-opioid Pain Patches Market Size YoY Growth 2016-2027
9.2 Europe Non-opioid Pain Patches Market Facts & Figures by Country
9.2.1 Europe Non-opioid Pain Patches Sales by Country (2016-2021)
9.2.2 Europe Non-opioid Pain Patches Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Non-opioid Pain Patches Market Size YoY Growth 2016-2027
10.2 Latin America Non-opioid Pain Patches Market Facts & Figures by Country
10.2.1 Latin America Non-opioid Pain Patches Sales by Country (2016-2021)
10.2.2 Latin America Non-opioid Pain Patches Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Non-opioid Pain Patches Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Non-opioid Pain Patches Market Facts & Figures by Country
11.2.1 Middle East and Africa Non-opioid Pain Patches Sales by Country (2016-2021)
11.2.2 Middle East and Africa Non-opioid Pain Patches Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Non-opioid Pain Patches Products Offered
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Non-opioid Pain Patches Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Non-opioid Pain Patches Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Corporation Information
12.4.2 Novartis AG Description and Business Overview
12.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis AG Non-opioid Pain Patches Products Offered
12.4.5 Novartis AG Recent Development
12.5 Mylan N.V.
12.5.1 Mylan N.V. Corporation Information
12.5.2 Mylan N.V. Description and Business Overview
12.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan N.V. Non-opioid Pain Patches Products Offered
12.5.5 Mylan N.V. Recent Development
12.6 Teva Pharmaceutical Industries
12.6.1 Teva Pharmaceutical Industries Corporation Information
12.6.2 Teva Pharmaceutical Industries Description and Business Overview
12.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Products Offered
12.6.5 Teva Pharmaceutical Industries Recent Development
12.7 Hisamitsu Pharmaceutical
12.7.1 Hisamitsu Pharmaceutical Corporation Information
12.7.2 Hisamitsu Pharmaceutical Description and Business Overview
12.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Products Offered
12.7.5 Hisamitsu Pharmaceutical Recent Development
12.8 TEH SENG Pharmaceutical
12.8.1 TEH SENG Pharmaceutical Corporation Information
12.8.2 TEH SENG Pharmaceutical Description and Business Overview
12.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.8.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Products Offered
12.8.5 TEH SENG Pharmaceutical Recent Development
12.9 Teikoku Seiyaku
12.9.1 Teikoku Seiyaku Corporation Information
12.9.2 Teikoku Seiyaku Description and Business Overview
12.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Teikoku Seiyaku Non-opioid Pain Patches Products Offered
12.9.5 Teikoku Seiyaku Recent Development
12.10 IBSA Institut Biochimque SA
12.10.1 IBSA Institut Biochimque SA Corporation Information
12.10.2 IBSA Institut Biochimque SA Description and Business Overview
12.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.10.4 IBSA Institut Biochimque SA Non-opioid Pain Patches Products Offered
12.10.5 IBSA Institut Biochimque SA Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Non-opioid Pain Patches Products Offered
12.11.5 Pfizer Recent Development
12.12 Allergan PLC
12.12.1 Allergan PLC Corporation Information
12.12.2 Allergan PLC Description and Business Overview
12.12.3 Allergan PLC Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Allergan PLC Products Offered
12.12.5 Allergan PLC Recent Development
12.13 Endo International
12.13.1 Endo International Corporation Information
12.13.2 Endo International Description and Business Overview
12.13.3 Endo International Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Endo International Products Offered
12.13.5 Endo International Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Non-opioid Pain Patches Industry Trends
13.2 Non-opioid Pain Patches Market Drivers
13.3 Non-opioid Pain Patches Market Challenges
13.4 Non-opioid Pain Patches Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Non-opioid Pain Patches Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Non-opioid Pain Patches Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Lidocaine Patch
Table 3. Major Manufacturers of Diclofenac Patch
Table 4. Major Manufacturers of Methyl Salicylate Patch
Table 5. Major Manufacturers of Capsaicin Patch
Table 6. Major Manufacturers of Ketoprofen Patch
Table 7. Major Manufacturers of Others
Table 8. Global Non-opioid Pain Patches Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 9. Global Non-opioid Pain Patches Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Non-opioid Pain Patches Sales by Regions (2016-2021) & (K Pcs)
Table 11. Global Non-opioid Pain Patches Sales Market Share by Regions (2016-2021)
Table 12. Global Non-opioid Pain Patches Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Non-opioid Pain Patches Sales Forecast by Region (2022-2027) & (K Pcs)
Table 14. Global Non-opioid Pain Patches Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Non-opioid Pain Patches Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Non-opioid Pain Patches Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Non-opioid Pain Patches Sales by Manufacturers (2016-2021) (K Pcs)
Table 18. Global Non-opioid Pain Patches Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Non-opioid Pain Patches Manufacturers by Revenue (US$ Million) in 2020
Table 20. Non-opioid Pain Patches Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Non-opioid Pain Patches Revenue Share by Manufacturers (2016-2021)
Table 22. Global Non-opioid Pain Patches Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Non-opioid Pain Patches by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-opioid Pain Patches as of 2020)
Table 24. Key Manufacturers Non-opioid Pain Patches Price (2016-2021) (USD/Pcs)
Table 25. Non-opioid Pain Patches Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Non-opioid Pain Patches Product Type
Table 27. Date of International Manufacturers Enter into Non-opioid Pain Patches Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Non-opioid Pain Patches Sales by Type (2016-2021) (K Pcs)
Table 30. Global Non-opioid Pain Patches Sales Share by Type (2016-2021)
Table 31. Global Non-opioid Pain Patches Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Non-opioid Pain Patches Revenue Share by Type (2016-2021)
Table 33. Non-opioid Pain Patches Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 34. Global Non-opioid Pain Patches Sales Forecast by Type (2022-2027) & (K Pcs)
Table 35. Global Non-opioid Pain Patches Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Non-opioid Pain Patches Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Non-opioid Pain Patches Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Non-opioid Pain Patches Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 39. Global Non-opioid Pain Patches Sales by Application (2016-2021) (K Pcs)
Table 40. Global Non-opioid Pain Patches Sales Share by Application (2016-2021)
Table 41. Global Non-opioid Pain Patches Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Non-opioid Pain Patches Revenue Share by Application (2016-2021)
Table 43. Non-opioid Pain Patches Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 44. Global Non-opioid Pain Patches Sales Forecast by Application (2022-2027) & (K Pcs)
Table 45. Global Non-opioid Pain Patches Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Non-opioid Pain Patches Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Non-opioid Pain Patches Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Non-opioid Pain Patches Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 49. China Non-opioid Pain Patches Sales (K Pcs) of Key Companies (2016-2021)
Table 50. China Non-opioid Pain Patches Sales Share by Company (2016-2021)
Table 51. China Non-opioid Pain Patches Revenue (US$ Million) by Company (2016-2021)
Table 52. China Non-opioid Pain Patches Revenue Share by Company (2016-2021)
Table 53. China Non-opioid Pain Patches Sales (K Pcs) by Type (2016-2021)
Table 54. China Non-opioid Pain Patches Sales Share by Type (2016-2021)
Table 55. China Non-opioid Pain Patches Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. China Non-opioid Pain Patches Price (USD/Pcs) by Type (2016-2021)
Table 57. China Non-opioid Pain Patches Sales (K Pcs) by Type (2022-2027)
Table 58. China Non-opioid Pain Patches Sales Share by Type (2022-2027)
Table 59. China Non-opioid Pain Patches Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. China Non-opioid Pain Patches Revenue Share by Type (2022-2027)
Table 61. China Non-opioid Pain Patches Price (USD/Pcs) by Type (2022-2027)
Table 62. China Non-opioid Pain Patches Sales (K Pcs) by Application (2016-2021)
Table 63. China Non-opioid Pain Patches Sales Share by Application (2016-2021)
Table 64. China Non-opioid Pain Patches Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. China Non-opioid Pain Patches Price (USD/Pcs) by Application (2016-2021)
Table 66. China Non-opioid Pain Patches Sales (K Pcs) by Application (2022-2027)
Table 67. China Non-opioid Pain Patches Sales Share by Application (2022-2027)
Table 68. China Non-opioid Pain Patches Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. China Non-opioid Pain Patches Revenue Share by Application (2022-2027)
Table 70. China Non-opioid Pain Patches Price (USD/Pcs) by Application (2022-2027)
Table 71. North America Non-opioid Pain Patches Sales by Country (2016-2021) & (K Pcs)
Table 72. North America Non-opioid Pain Patches Sales Market Share by Country (2016-2021)
Table 73. North America Non-opioid Pain Patches Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Non-opioid Pain Patches Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Non-opioid Pain Patches Sales by Region (2016-2021) & (K Pcs)
Table 76. Asia Pacific Non-opioid Pain Patches Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Non-opioid Pain Patches Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Non-opioid Pain Patches Revenue Market Share by Region (2016-2021)
Table 79. Europe Non-opioid Pain Patches Sales by Country (2016-2021) & (K Pcs)
Table 80. Europe Non-opioid Pain Patches Sales Market Share by Country (2016-2021)
Table 81. Europe Non-opioid Pain Patches Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Non-opioid Pain Patches Revenue Market Share by Country (2016-2021)
Table 83. Latin America Non-opioid Pain Patches Sales by Country (2016-2021) & (K Pcs)
Table 84. Latin America Non-opioid Pain Patches Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Non-opioid Pain Patches Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Non-opioid Pain Patches Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Non-opioid Pain Patches Sales by Country (2016-2021) & (K Pcs)
Table 88. Middle East and Africa Non-opioid Pain Patches Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Non-opioid Pain Patches Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Non-opioid Pain Patches Revenue Market Share by Country (2016-2021)
Table 91. Pfizer Corporation Information
Table 92. Pfizer Description and Business Overview
Table 93. Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 94. Pfizer Non-opioid Pain Patches Product
Table 95. Pfizer Recent Development
Table 96. GlaxoSmithKline Corporation Information
Table 97. GlaxoSmithKline Description and Business Overview
Table 98. GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 99. GlaxoSmithKline Product
Table 100. GlaxoSmithKline Recent Development
Table 101. Johnson & Johnson Corporation Information
Table 102. Johnson & Johnson Description and Business Overview
Table 103. Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 104. Johnson & Johnson Product
Table 105. Johnson & Johnson Recent Development
Table 106. Novartis AG Corporation Information
Table 107. Novartis AG Description and Business Overview
Table 108. Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 109. Novartis AG Product
Table 110. Novartis AG Recent Development
Table 111. Mylan N.V. Corporation Information
Table 112. Mylan N.V. Description and Business Overview
Table 113. Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 114. Mylan N.V. Product
Table 115. Mylan N.V. Recent Development
Table 116. Teva Pharmaceutical Industries Corporation Information
Table 117. Teva Pharmaceutical Industries Description and Business Overview
Table 118. Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 119. Teva Pharmaceutical Industries Product
Table 120. Teva Pharmaceutical Industries Recent Development
Table 121. Hisamitsu Pharmaceutical Corporation Information
Table 122. Hisamitsu Pharmaceutical Description and Business Overview
Table 123. Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 124. Hisamitsu Pharmaceutical Product
Table 125. Hisamitsu Pharmaceutical Recent Development
Table 126. TEH SENG Pharmaceutical Corporation Information
Table 127. TEH SENG Pharmaceutical Description and Business Overview
Table 128. TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 129. TEH SENG Pharmaceutical Product
Table 130. TEH SENG Pharmaceutical Recent Development
Table 131. Teikoku Seiyaku Corporation Information
Table 132. Teikoku Seiyaku Description and Business Overview
Table 133. Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 134. Teikoku Seiyaku Product
Table 135. Teikoku Seiyaku Recent Development
Table 136. IBSA Institut Biochimque SA Corporation Information
Table 137. IBSA Institut Biochimque SA Description and Business Overview
Table 138. IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 139. IBSA Institut Biochimque SA Product
Table 140. IBSA Institut Biochimque SA Recent Development
Table 141. Acorda Therapeutics Corporation Information
Table 142. Acorda Therapeutics Description and Business Overview
Table 143. Acorda Therapeutics Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 144. Acorda Therapeutics Product
Table 145. Acorda Therapeutics Recent Development
Table 146. Allergan PLC Corporation Information
Table 147. Allergan PLC Description and Business Overview
Table 148. Allergan PLC Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 149. Allergan PLC Product
Table 150. Allergan PLC Recent Development
Table 151. Endo International Corporation Information
Table 152. Endo International Description and Business Overview
Table 153. Endo International Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 154. Endo International Product
Table 155. Endo International Recent Development
Table 156. Non-opioid Pain Patches Market Trends
Table 157. Non-opioid Pain Patches Market Drivers
Table 158. Non-opioid Pain Patches Market Challenges
Table 159. Non-opioid Pain Patches Market Restraints
Table 160. Non-opioid Pain Patches Customers List
Table 161. Non-opioid Pain Patches Distributors List
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-opioid Pain Patches Product Picture
Figure 2. Global Non-opioid Pain Patches Sales Market Share by Type in 2020 & 2027
Figure 3. Lidocaine Patch Product Picture
Figure 4. Diclofenac Patch Product Picture
Figure 5. Methyl Salicylate Patch Product Picture
Figure 6. Capsaicin Patch Product Picture
Figure 7. Ketoprofen Patch Product Picture
Figure 8. Others Product Picture
Figure 9. Global Non-opioid Pain Patches Sales Market Share by Application in 2020 & 2027
Figure 10. Hospital Pharmacies
Figure 11. Independent Pharmacies & Drug Stores
Figure 12. Online Pharmacies
Figure 13. Non-opioid Pain Patches Report Years Considered
Figure 14. Global Non-opioid Pain Patches Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Non-opioid Pain Patches Market Size 2016-2027 (US$ Million)
Figure 16. Global Non-opioid Pain Patches Sales 2016-2027 (K Pcs)
Figure 17. Global Non-opioid Pain Patches Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Non-opioid Pain Patches Sales Market Share by Region (2016-2021)
Figure 19. Global Non-opioid Pain Patches Sales Market Share by Region in 2020
Figure 20. Global Non-opioid Pain Patches Revenue Market Share by Region (2016-2021)
Figure 21. Global Non-opioid Pain Patches Revenue Market Share by Region in 2020
Figure 22. Global Non-opioid Pain Patches Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Non-opioid Pain Patches Revenue in 2020
Figure 24. Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Non-opioid Pain Patches Sales Market Share by Type (2016-2021)
Figure 26. Global Non-opioid Pain Patches Sales Market Share by Type in 2020
Figure 27. Global Non-opioid Pain Patches Revenue Market Share by Type (2016-2021)
Figure 28. Global Non-opioid Pain Patches Revenue Market Share by Type in 2020
Figure 29. Global Non-opioid Pain Patches Sales Market Share by Application (2016-2021)
Figure 30. Global Non-opioid Pain Patches Sales Market Share by Application in 2020
Figure 31. Global Non-opioid Pain Patches Revenue Market Share by Application (2016-2021)
Figure 32. Global Non-opioid Pain Patches Revenue Market Share by Application in 2020
Figure 33. China Non-opioid Pain Patches Sales Growth Rate 2016-2027 (K Pcs)
Figure 34. China Non-opioid Pain Patches Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. China Non-opioid Pain Patches Market Share in Global Market 2016-2027
Figure 36. China 5 and 10 Largest Non-opioid Pain Patches Players Market Share by Revenue in Non-opioid Pain Patches in 2020
Figure 37. China Non-opioid Pain Patches Revenue Share by Type (2016-2021)
Figure 38. China Non-opioid Pain Patches Revenue Growth Rate by Type in 2016 & 2020
Figure 39. China Non-opioid Pain Patches Revenue Share by Application (2016-2021)
Figure 40. China Non-opioid Pain Patches Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America Non-opioid Pain Patches Sales Growth Rate 2016-2021 (K Pcs)
Figure 42. North America Non-opioid Pain Patches Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America Non-opioid Pain Patches Sales Market Share by Country in 2020
Figure 44. North America Non-opioid Pain Patches Revenue Market Share by Country in 2020
Figure 45. U.S. Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 46. U.S. Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 48. Canada Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe Non-opioid Pain Patches Sales Growth Rate 2016-2021 (K Pcs)
Figure 50. Europe Non-opioid Pain Patches Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe Non-opioid Pain Patches Sales Market Share by Country in 2020
Figure 52. Europe Non-opioid Pain Patches Revenue Market Share by Country in 2020
Figure 53. Germany Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 54. Germany Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. France Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 56. France Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. U.K. Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. U.K. Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Italy Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 60. Italy Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Russia Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 62. Russia Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Asia Pacific Non-opioid Pain Patches Sales Growth Rate 2016-2021 (K Pcs)
Figure 64. Asia Pacific Non-opioid Pain Patches Revenue Growth Rate 2016-2021 (US$ Million)
Figure 65. Asia Pacific Non-opioid Pain Patches Sales Market Share by Region in 2020
Figure 66. Asia Pacific Non-opioid Pain Patches Revenue Market Share by Region in 2020
Figure 67. China Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 68. China Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Japan Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 70. Japan Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. South Korea Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 72. South Korea Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. India Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 74. India Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Australia Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 76. Australia Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Taiwan Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 78. Taiwan Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Indonesia Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 80. Indonesia Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Thailand Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 82. Thailand Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Malaysia Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 84. Malaysia Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Philippines Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 86. Philippines Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Vietnam Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 88. Vietnam Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Latin America Non-opioid Pain Patches Sales Growth Rate 2016-2021 (K Pcs)
Figure 90. Latin America Non-opioid Pain Patches Revenue Growth Rate 2016-2021 (US$ Million)
Figure 91. Latin America Non-opioid Pain Patches Sales Market Share by Country in 2020
Figure 92. Latin America Non-opioid Pain Patches Revenue Market Share by Country in 2020
Figure 93. Mexico Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 94. Mexico Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Brazil Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 96. Brazil Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Argentina Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 98. Argentina Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Middle East and Africa Non-opioid Pain Patches Sales Growth Rate 2016-2021 (K Pcs)
Figure 100. Middle East and Africa Non-opioid Pain Patches Revenue Growth Rate 2016-2021 (US$ Million)
Figure 101. Middle East and Africa Non-opioid Pain Patches Sales Market Share by Country in 2020
Figure 102. Middle East and Africa Non-opioid Pain Patches Revenue Market Share by Country in 2020
Figure 103. Turkey Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 104. Turkey Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Saudi Arabia Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 106. Saudi Arabia Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. U.A.E Non-opioid Pain Patches Sales Growth Rate (2016-2021) (K Pcs)
Figure 108. U.A.E Non-opioid Pain Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. Non-opioid Pain Patches Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.